 |
With
much pre-press fanfare, the New England Journal of Medicine
(NEJM) released a "negative" study on the herb Echinacea
Angustifolia in the July 28, 2005 issue of the journal. In the
study, a group of medical students were infected with an "experimental
rhinovirus." Seven days passed, then one group of students received
five days of treatment from a single lot of a prepared Ecinacea product.
The results, not surprisingly for a study published by NEJM on herbal
medicine, showed that |
there was no effect for treatment of this experimental rhinovirus
using Echinacea. A perspectives article in the same issue of the
journal by Wallace Sampson went so far as to conclude that Echinacea
is ineffective in boosting the immune system in any way whatsoever.
This seems like a rather broad claim for an herb that has, in fact,
been used effectively for hundreds of years and has dozens upon
dozens of positive journal studies in its favor! I wonder what Sampson's
theory is for why tens of millions of people over hundreds of years
have used Echinacea successfully and repeatedly for treating colds
if it is as worthless a plant as he suggests in his piece?
Understanding
the study and how it was set up will show why the experiment "failed"
(how it was designed to fail, in fact). So, let's look at what is
wrong with this study and why real conclusions cannot be drawn from
it:
- The
group being treated with Echinacea was given 1.5 ml of a 1:5 tincture
of Echinacea angustifolia three times per day. Echinacea
for the immune system is like gasoline in a car. The harder and
faster you run your car, the more gas you have to put in it.
- Without
having to understand extraction ratios and what tinctures
are, etc, suffice to say that 4.5 ml of a 1:5 extract is a
very small amount of Echinacea, particularly when being given
to a patient in the acute stages of an infection. It would
not be uncommon for an American herbalist to use about 0.5
ml of this strength of tincture every 15-30 minutes for a
patient who is acutely sick!
- The
dosage equaled about 900 mg of Echinacea angustifolia
root per day. Kerry Bone, researcher at MediHerb, Inc. and
probably the world's leader in the cultivation and extraction
of Echinacea, gives a guideline of using 2,000 mg per day
of high quality root, over twice what the NEJM study used.
-
Like pharmaceutical medicine, dosage is critical for herbal
medicine, both in terms of the quality of the extract, amount
given, the form given (liquid versus tablet), as well as the
timing of the dosages.
- One
of the authors of the study, Dr. David Gangemi, stated "I
think in retrospect if we go back and we look at some of the other
products that are out there maybe we’re only one tenth the
level we should be."
- The
question that herbalists ask repeatedly when so-called "negative"
studies on herbs are presented in medical journals is why
real, practicing herbalists are not consulted in designing
the study. How much credence would be given a study on a medication
if it used a poor grade of the medicine, less than a therapeutic
dosage, etc? None at all, yet this same lack of standards
is applied to herbal medicine all the time, resulting in conflicting
evidence about the efficacy of the herb.
- This
study, despite being poorly designed and using a flawed clinical
method, is one of a mountain of evidence that has been compiled
about Echinacea over the last hundred years. The research really
shouldn't even be considered since its design is so flawed, but
one needs to only open a textbook like Kerry Bone's Principles
and Practice of Phytotherapy or David Hoffmann's Medical
Herbalismto see dozens of well-designed clinical trials that
do, in fact, show a measurable effect of Echinacea on the human
immune system.
Unfortunately,
mainstream medicine, particularly the medical journals, have a grave
misunderstanding of herbal medicine and therefore approach any study
having to do with it with a negative bias. In recent years these
same journals have discredited Kava needlessly (interestingly, reports
of problems with kava originated in Germany, where kava had for
the first time outsold Prozac for use in depression), St John's
Wort (also through poorly designed studies) and others. |